Methotrexate-Loaded Chitosan Oligosaccharide-ES2 for Targeted Cancer Therapy-Reference-Cited by-同舟云学术

Methotrexate-Loaded Chitosan Oligosaccharide-ES2 for Targeted Cancer Therapy

Published:2024-08-20 Issue:34 Volume:16 Page:44409-44427
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Tang Wen¹²³,Hou Huiwen¹²³,Wang Hanlin¹²³,Gao Xinqing¹²³,Zhao Feiyan¹²³,Di Yuhan¹²³,Ji Shengli¹⁴,Ling Peixue¹²⁵,Wang Fengshan¹²³⁵^ORCID,Sun Feng¹²³⁵,Tan Haining¹²³⁵^ORCID

Affiliation:

1. National Glycoengineering Research Center, Shandong University, Qingdao 266237, Shandong, China

2. NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, Shandong University, Qingdao 266237, China

3. Shandong Provincial Technology Innovation Center of Carbohydrate, Shandong University, Qingdao 266237, China

4. ReaLi Tide Biological Technology (Weihai) Co., Ltd, Weihai 264207, China

5. School of Pharmaceutical sciences, Shandong University, Jinan 250012, China

Funder

National Key Research and Development Program of China

Fundamental Research Funds for the Central Universities

Key Technology Research and Development Program of Shandong Province

Foundation for Young Scholars of Shandong Province

Central Government Guide Local Science and Technology Development Funds

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.4c06656

Reference42 articles.

1. Anti-Angiogenesis

2. Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action

3. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth

4. Hyaluronic acid-endostatin2-alft1 (HA-ES2-AF) nanoparticle-like conjugate for the target treatment of diseases

5. An Endostatin-derived Peptide Interacts with Integrins and Regulates Actin Cytoskeleton and Migration of Endothelial Cells